2019
DOI: 10.1093/jb/mvz071
|View full text |Cite
|
Sign up to set email alerts
|

Cooperative action of APJ and α1A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction

Abstract: The apelin receptor (APJ), a receptor for apelin and elabela/apela, induces vasodilation and vasoconstriction in blood vessels. However, the prolonged effects of increased APJ-mediated signalling, involving vasoconstriction, in smooth muscle cells have not been fully characterized. Here, we investigated the vasoactive effects of APJ gain of function under the control of the smooth muscle actin (SMA) gene promoter in mice. Transgenic overexpression of APJ (SMA-APJ) conferred sensitivity to blood pressure and va… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 38 publications
0
6
0
Order By: Relevance
“…Apelin acts via binding to G-proteincoupled-receptors known as APJ receptors, which are widely expressed throughout the cardiovascular system (Katugampola et al, 2001;Kleinz et al, 2005;Pitkin et al, 2010;Luo et al, 2018). An increasing body of evidence indicates that the apelin-APJ receptor signaling system regulates vascular function in mammalian arteries and veins (Gurzu et al, 2006;Jia et al, 2007;Salcedo et al, 2007;Wang et al, 2016;Nagano et al, 2019), including those from humans (Katugampola et al, 2001;Kleinz and Davenport, 2004;Maguire et al, 2009;Schinzari et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Apelin acts via binding to G-proteincoupled-receptors known as APJ receptors, which are widely expressed throughout the cardiovascular system (Katugampola et al, 2001;Kleinz et al, 2005;Pitkin et al, 2010;Luo et al, 2018). An increasing body of evidence indicates that the apelin-APJ receptor signaling system regulates vascular function in mammalian arteries and veins (Gurzu et al, 2006;Jia et al, 2007;Salcedo et al, 2007;Wang et al, 2016;Nagano et al, 2019), including those from humans (Katugampola et al, 2001;Kleinz and Davenport, 2004;Maguire et al, 2009;Schinzari et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…The synergistic effects of the other receptors may have profound implications on the pathogenesis of AD and CAA. For example, the vasoconstriction generated by agonists of the α 1A -ARs is enhanced by stimulation of the apelin receptor [26]. Genetic deficiency of the α 2A -AR significantly reduces Aβ generation, whereas stimulation of this receptor enhances it [27].…”
Section: Discussionmentioning
confidence: 99%
“…Its activation causes stimulation of PLC-β, which cleaves PIP2 into DAG and IP3. This increased intracellular IP3 binds to its receptors, leading to higher iCa 2+ levels and subsequent myosin phosphorylation ( 250 , 251 ). The result of this pathway is a peripheral vasoconstriction that reverses peripheral vasodilation alleviating hypotension and reducing edema ( 252 , 253 ).…”
Section: Treatmentmentioning
confidence: 99%